BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 12, 2010
View Archived Issues
Novel M. tuberculosis methionine aminopeptidase inhibitors identified
Read More
Variations in fentanyl sensitivity correlated with OPRM1 gene polymorphisms
Read More
Gene recurrence score may be useful for prognosis in node-positive breast cancer
Read More
Javelin reports phase III trial data for Ereska
Read More
Nymox provides update on pivotal phase III NX-1207 trials for BPH
Read More
Phase II study evaluates droxidopa in combination with carbidopa in adult ADHD
Read More
StemCells' HuCNS-SC human neural stem cells used in myelination disorder trial
Read More
FDA accepts Alexza's AZ-004 NDA for filing
Read More
Data Monitoring Committee recommends continuation of phase III StemEx trial
Read More
Correlation between higher blood lead levels and adverse mental health outcomes
Read More
Oral cladribine reduces rate of multiple sclerosis relapse in phase III trial
Read More
LEK Pharmaceuticals describes novel broad spectrum antibacterial agents
Read More
Amura Therapeutics discovers novel CAC1 cysteine protease inhibitors
Read More
Aegera presents novel IAP inhibitors
Read More
Otsuka Pharmaceutical describes novel monoamine reuptake inhibitors
Read More
Ligon Discovery and Lycera collaborate to develop drugs for immune disorders
Read More
Data Monitoring Committee recommends continuation of phase III ThermoDox trial
Read More
QRxPharma initiates second pivotal phase III MoxDuoIR dual-opioid trial
Read More
Antisense provides update on ATL-1101
Read More
Astellas reports third quarter 2009 results
Read More
Lundbeck claims the identification of novel PDE10 inhibitors
Read More
FDA grants approval to Daiichi's hypertension treatment Benicar in pediatric patients
Read More
Living Cell Technologies receives government grant for Diabecell
Read More
3SBio and Ascentage enter into strategic alliance for targeted cancer therapeutics
Read More
Shenogen and Chemizon sign agreement for ERalpha receptor modulators
Read More